Abstract
Angiogenesis-targeting agents, predominantly inhibitors of vascular endothelial growth factor and its receptors, have become a mainstay in oncology practice over the last decade. The approved drugs, which include two antibodies and seven small molecule inhibitors, represent strong validation for the field of anti-angiogenesis in the treatment of cancer. In addition to ongoing clinical studies assessing new indications for these agents, novel inhibitors are undergoing clinical evaluations and combination therapies of anti-angiogenic drugs with other targeted approaches are being investigated. This chapter will review the development of the currently marketed drugs targeting VEGFR, as well as the new inhibitors currently being assessed in the clinic.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
FDA approved drug products. https://www.accessdata.fda.gov/scripts/cder/drugsatfda/
Folkman J (2007) Nat Rev Drug Discov 6:273
Holmes K, Roberts OL, Thomas AM, Cross MJ (2007) Cell Signal 19:2003
Stuttfeld E, Ballmer-Hofer K (2009) IUBMB Life 61:915
Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006) Nat Rev Mol Cell Biol 7:359
Ferrara N (2011) Int J Dev Biol 55:383
Ferrara N, Hillan KJ, Gerber H-P, Novotny W (2004) Nat Rev Drug Discov 3:391
Gordon MS, Margolin K, Talpaz M, Sledge Jr GW, Holmgren E, Benjamin R, Stalter S, Shak S, Adelman D (2001) J Clin Oncol 19:843
Lu JF, Bruno R, Eppler S, Novotny W, Lum B, Gaudreault J (2008) Cancer Chemother Pharmacol 62:779
Keating GM (2014) Drugs 74:1891
Hurwitz HI, Fehrenbacher L, Hainsworth JD, Heim W, Berlin J, Holmgren E, Hambleton J, Novotny WF, Kabbinavar F (2005) J Clin Oncol 23:3502
Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH (2006) N Engl J Med 355:2542
Escudier B, Bellmunt J, Négrier S, Bajetta E, Melichar B, Bracarda S, Ravaud A, Golding S, Jethwa S, Sneller V (2010) J Clin Oncol 28:2144
Tewari KS, Sill MW, Long 3rd HJ, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael HE, Monk BJ (2014) N Engl J Med 370:734
Pujade-Lauraine E, Hilpert F, Weber B, Reuss A, Poveda A, Kristensen G, Sorio R, Vergote I, Witteveen P, Bamias A, Pereira D, Wimberger P, Oaknin A, Mirza MR, Follana P, Bollag D, Ray-Coquard I (2014) J Clin Oncol 32:1302
Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S, Won M, Jeraj R, Brown PD, Jaeckle KA, Schiff D, Stieber VW, Brachman DG, Werner-Wasik M, Tremont-Lukats IW, Sulman EP, Aldape KD, Curran Jr WJ, Mehta MP (2014) N Engl J Med 370:699
Zalcman G, Mazières J, Margery J, Greillier L, Audigier-Valette C, Moro-Sibilot D, Molinier O, Corre R, Monnet I, Gounant V, Janicot H, Gervais R, Locher C, Milleron B, Tran Q, Lebitasy MP, Morin F, Creveuil C, Parienti J-J, Scherpereel A (2015) J Clin Oncol 33(Suppl); abstr 7500
Wilhelm S, Carter C, Lynch M, Lowinger T, Dumas J, Smith RA, Schwartz B, Simantov R, Kelley S (2006) Nat Rev Drug Discov 5:835
Mangana J, Levesque MP, Karpova MB, Dummer R (2012) Exp Opin Invest Drugs 21:557
McTigue MA, Wickersham JA, Pinko C, Showalter RE, Parast CV, Tempczyk-Russell A, Gehring MR, Mroczkowski B, Kan CC, Villafranca JE, Appelt K (1999) Structure 7:319
McTigue M, Murray BW, Chen JH, Deng YL, Solowiej J, Kania RS (2012) Proc Natl Acad Sci U S A 109:18281
Strumberg D, Richly H, Hilger RA, Schleucher N, Korfee S, Tewes M, Faghih M, Brendel E, Voliotis D, Haase CG, Schwartz B, Awada A, Voigtmann R, Scheulen ME, Seeber S (2005) J Clin Oncol 23:965
Ratain MJ, Eisen T, Stadler WM, Flaherty KT, Kaye SB, Rosner GL, Gore M, Desai AA, Patnaik A, Xiong HQ, Rowinsky E, Abbruzzese JL, Xia C, Simantov R, Schwartz B, O’Dwyer PJ (2006) J Clin Oncol 24:2505
Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Staehler M, Negrier S, Chevreau C, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Anderson S, Hofilena G, Shan M, Pena C, Lathia C, Bukowski RM (2009) J Clin Oncol 27:3312
Liu L, Cao Y, Chen C, Zhang X, McNabola A, Wilkie D, Wilhelm S, Lynch M, Carter C (2006) Cancer Res 66:11851
Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J (2008) N Engl J Med 359:378
Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, Bastholt L, de la Fouchardiere C, Pacini F, Paschke R, Shong YK, Sherman SI, Smit JW, Chung J, Kappeler C, Peña C, Molnár I, Schlumberger MJ (2014) Lancet 384:319
Sun CL, Christensen JG, McMahon G (2009) Discovery and development of sunitinib (SU11248): a multitarget tyrosine kinase inhibitor of tumor growth, survival, and angiogenesis. In: Li R, Stafford JA (eds) Kinase inhibitor drugs. Wiley, Hoboken, p. 1
Britten CD, Kabbinavar F, Hecht JR, Bello CL, Li J, Baum C, Slamon D (2008) Cancer Chemother Pharmacol 61:515
Faivre S, Delbaldo C, Vera K, Robert C, Lozahic S, Lassau N, Bello C, Deprimo S, Brega N, Massimini G, Armand JP, Scigalla P, Raymond E (2006) J Clin Oncol 24:25
Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, Chen I, Bycott PW, Baum CM, Figlin RA (2007) N Engl J Med 356:115
Demetri GD, van Oosterom AT, Garrett CR, Blackstein ME, Shah MH, Verweij J, McArthur G, Judson IR, Heinrich MC, Morgan JA, Desai J, Fletcher CD, George S, Bello CL, Huang X, Baum CM, Casali PG (2006) Lancet 368:1329
Raymond E, Dahan L, Raoul JL, Bang YJ, Borbath I, Lombard-Bohas C, Valle J, Metrakos P, Smith D, Vinik A, Chen JS, Hörsch D, Hammel P, Wiedenmann B, Van Cutsem E, Patyna S, Lu DR, Blanckmeister C, Chao R, Ruszniewski P (2011) N Engl J Med 364:501
Harris PA, Stafford JA (2009) Discovery of pazopanib, a pan vascular endothelial growth factor kinase inhibitor. In: Li R, Stafford JA (eds) Kinase inhibitor drugs. Wiley, Hoboken, p. 57
Kumar R, Knick VB, Rudolph SK, Johnson JH, Crosby RM, Crouthamel MC, Hopper TM, Miller CG, Harrington LE, Onori JA, Mullin RJ, Gilmer TM, Truesdale AT, Epperly AH, Boloor A, Stafford JA, Luttrell DK, Cheung M (2007) Mol Cancer Ther 6:2012
Hurwitz H, Dowlati A, Savage S, Fernando N, Lasalvia S, Whitehead B, Suttle B, Collins D, Ho P, Pandite L (2005) J Clin Oncol 23:3012
Hutson TE, Davis ID, Machiels JH, de Souza PL, Baker K, Bordogna W, Westlund R, Crofts T, Pandite L, Figlin RA (2008) J Clin Oncol 26:5046
Sternberg CN, Davis ID, Mardiak J, Szczylik C, Lee E, Wagstaff J, Barrios CH, Salman P, Gladkov OA, Kavina A, Zarbá JJ, Chen M, McCann L, Pandite L, Roychowdhury DF, Hawkins RE (2010) J Clin Oncol 28:1061
Sleijfer S, Papai Z, Le Cesne A, Scurr M, Ray-Coquard I, Collin F, Pandite L, Marreaud S, De Brauwer A, Blay J (2007) J Clin Oncol 25:10031
van der Graaf WT, Blay JY, Chawla SP, Kim DW, Bui-Nguyen B, Casali PG, Schöffski P, Aglietta M, Staddon AP, Beppu Y, Le Cesne A, Gelderblom H, Judson IR, Araki N, Ouali M, Marreaud S, Hodge R, Dewji MR, Coens C, Demetri GD, Fletcher CD, Dei Tos AP, Hohenberger P (2012) Lancet 379:1879
Kania RS (2009) Structure-based design and characterization of axitinib. In: Li R, Stafford JA (eds) Kinase inhibitor drugs. Wiley, Hoboken, p. 167
Rugo HS, Herbst RS, Liu G, Park JW, Kies MS, Steinfeldt HM, Pithavala YK, Reich SD, Freddo JL, Wilding G (2005) J Clin Oncol 23:5474
Rini BI, Wilding G, Hudes G, Stadler WM, Kim S, Tarazi J, Rosbrook B, Trask PC, Wood L, Dutcher JP (2009) J Clin Oncol 27:4462
Motzer RJ, Escudier B, Tomczak P, Hutson TE, Michaelson MD, Negrier S, Oudard S, Gore ME, Tarazi J, Hariharan S, Chen C, Rosbrook B, Kim S, Rini BI (2013) Lancet Oncol 14:552
Spano J, Chodkiewicz C, Maurel J, Wong RP, Wasan HS, Pithavala YK, Bycott PW, Liau K, Kim S, Rixe O (2007) J Clin Oncol 25:4551
Kindler HL, Ioka T, Richel DJ, Bennouna J, Létourneau R, Okusaka T, Funakoshi A, Furuse J, Park YS, Ohkawa S, Springett GM, Wasan HS, Trask PC, Bycott P, Ricart AD, Kim S, Van Cutsem E (2011) Lancet Oncol 12:256
Davis SL, Eckhardt SG, Messersmith WA, Jimeno A (2013) Drugs Today 49:105
Mross K, Frost A, Steinbild S, Hedbom S, Büchert M, Fasol U, Unger C, Krätzschmar J, Heinig R, Boix O, Christensen O (2012) Clin Cancer Res 18:2658
Grothey A, Sobrero AF, Siena S, Falcone A, Ychou M, Lenz H-J, Yoshino T, Cihon F, Wagner A, Van Cutsem E (2012) J Clin Oncol 30(Suppl 4); abstr LBA385
Demetri GD, Reichardt P, Kang Y-K, Blay J-Y, Joensuu H, Maki RG, Rutkowski P, Hohenberger P, Gelderblom H, Leahy MG, von Mehren M, Schoffski P, Blackstein ME, Le Cesne A, Badalamenti G, Xu J-M, Nishida T, Laurent D, Kuss I, Casali PG (2012) J Clin Oncol 30(Suppl); abstr LBA10008
Bruix J, Tak WY, Gasbarrini A, Santoro A, Colombo M, Lim HY, Mazzaferro V, Wiest R, Reig M, Wagner A, Bolondi L (2013) Eur J Cancer 49:3412
Roth GJ, Binder R, Colbatzky F, Dallinger C, Schlenker-Herceg R, Hilberg F, Wollin SL, Kaiser R (2015) J Med Chem 58:1053
Hilberg F, Roth GJ, Krssak M, Kautschitsch S, Sommergruber W, Tontsch-Grunt U, Garin-Chesa P, Bader G, Zoephel A, Quant J, Heckel A, Rettig WJ (2008) Cancer Res 68:4774
Matsui J, Yamamoto Y, Funahashi Y, Tsuruoka A, Watanabe T, Wakabayashi T, Uenaka T, Asada M (2008) Int J Cancer 122:664
Okamoto K, Ikemori-Kawada M, Jestel A, von König K, Funahashi Y, Matsushima T, Tsuruoka A, Inoue A, Matsui J (2014) ACS Med Chem Lett 6:89
Nakamichi S, Nokihara H, Yamamoto N, Yamada Y, Honda K, Tamura Y, Wakui H, Sasaki T, Yusa W, Fujino K, Tamura T (2015) Cancer Chemother Pharmacol 76:1153
Schlumberger M, Tahara M, Wirth LJ, Robinson B, Brose MS, Elisei R, Habra MA, Newbold K, Shah MH, Hoff AO, Gianoukakis AG, Kiyota N, Taylor MH, Kim SB, Krzyzanowska MK, Dutcus CE, de las Heras B, Zhu J, Sherman SI (2015) N Engl J Med 372:621
Sorbera LA, Serradell N, Rosa E, Bolós J, Bayés M (2007) Drugs Future 32:577
Schmidt C (2015) J Natl Cancer Inst 107:3
Sahade M, Caparelli F, Hoff PM (2012) Future Oncol 8:775
Haberkorn BC, Eskens FA (2013) Future Oncol 9:13
Jamil MO, Hathaway A, Mehta A (2015) Curr Oncol Rep 17:24
Benson A, Krivoshik A, Van Sant C, Needle M (2015) Ann Oncol 26(Suppl 4):108
Porta C, Giglione P, Liguigli W, Paglino C (2015) Future Oncol 11:39
Tian S, Quan H, Xie C, Guo H, Lü F, Xu Y, Li J, Lou L (2011) Cancer Sci 102:1374
Scagliotti GV, Vynnychenko I, Park K, Ichinose Y, Kubota K, Blackhall F, Pirker R, Galiulin R, Ciuleanu TE, Sydorenko O, Dediu M, Papai-Szekely Z, Banaclocha NM, McCoy S, Yao B, Hei YJ, Galimi F, Spigel DR (2012) J Clin Oncol 30:2829
Johnson PJ, Qin S, Park JW, Poon RT, Raoul JL, Philip PA, Hsu CH, Hu TH, Heo J, Xu J, Lu L, Chao Y, Boucher E, Han KH, Paik SW, Robles-Aviña J, Kudo M, Yan L, Sobhonslidsuk A, Komov D, Decaens T, Tak WY, Jeng LB, Liu D, Ezzeddine R, Walters I, Cheng AL (2013) J Clin Oncol 31:3517
Llovet JM, Decaens T, Raoul JL, Boucher E, Kudo M, Chang C, Kang YK, Assenat E, Lim HY, Boige V, Mathurin P, Fartoux L, Lin DY, Bruix J, Poon RT, Sherman M, Blanc JF, Finn RS, Tak WY, Chao Y, Ezzeddine R, Liu D, Walters I, Park JW (2013) J Clin Oncol 31:3509
Siu LL, Shapiro JD, Jonker DJ, Karapetis CS, Zalcberg JR, Simes J, Couture F, Moore MJ, Price TJ, Siddiqui J, Nott LM, Charpentier D, Liauw W, Sawyer MB, Jefford M, Magoski NM, Haydon A, Walters I, Ringash J, Tu D, O’Callaghan CJ (2013) J Clin Oncol 31:2477
Cainap C, Qin S, Huang WT, Chung IJ, Pan H, Cheng Y, Kudo M, Kang YK, Chen PJ, Toh HC, Gorbunova V, Eskens FA, Qian J, McKee MD, Ricker JL, Carlson DM, El-Nowiem S (2015) J Clin Oncol 33:172
Sobrero AF, Bruzzi P (2011) J Clin Oncol 29:1938
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Harris, P.A. (2017). Inhibitors of Vascular Endothelial Growth Factor Receptor. In: Waring, M.J. (eds) Cancer II. Topics in Medicinal Chemistry, vol 28. Springer, Cham. https://doi.org/10.1007/7355_2016_28
Download citation
DOI: https://doi.org/10.1007/7355_2016_28
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-75924-1
Online ISBN: 978-3-319-75926-5
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)